Sensitive and Accurate HIV Genotyping and DRM analysis
The Sentosa® SQ HIV Genotyping Assay uses next-generation sequencing technology to deliver accuracy in the detection of the HIV-1 Group M subtypes A through K as well as drug resistance mutations (DRMs). Compared with traditional methods for HIV genotyping such Sanger sequencing, this next-generation sequencing-based assay is fast, delivering results in days rather than weeks, and identifies drug resistance mutations with greater sensitivity.
Reliable and reproducible, this assay is designed for routine use with the Sentosa® SQ workflow. By integrating genotyping and DRM identification into a single automated workflow, the need to run multiple assays is eliminated. This significantly improves turn-around-time to only 2 days from sample to annotated report with just 2.5 hours of hands-on-time.